A Comprehensive Lifestyle Intervention to Prevent Type 2 Diabetes and Cardiovascular Diseases: the German CHIP Trial
- 1k Downloads
The prevalence of type 2 diabetes is continuously increasing. This chronic metabolic disorder is difficult to treat and imposes a considerable economic burden on the healthcare system. In view of the fact that type 2 diabetes is primarily caused by behavioral factors, effective preventive strategies are urgently needed. We examined the effects of a holistic lifestyle intervention on clinical and laboratory parameters as well as on the long-term diabetes risk in patients at risk to develop diabetes. We conducted a randomized controlled trial in a primary care setting in Hannover, Germany, with 83 patients diagnosed as (pre)diabetic or at risk for diabetes. CHIP Germany is a 40-hour coaching lifestyle intervention program for the primary and secondary prevention of type 2 diabetes and cardiovascular diseases. The intervention included a comprehensive nutrition and health educational program based on the American CHIP approach. The primary outcome parameter was the body mass index (BMI). Secondary outcome parameters included body weight, blood pressure, fasting glucose, HbA1c, blood lipids, and the FINDRISK score, which assesses long-term diabetes risk. At the final measurement after 12 months, in the intervention group the BMI was reduced by 1.4 versus 0.2 kg/m2 in controls (p = .119). The mean sustained weight loss after 12 months was −4.1 kg in the intervention group versus −0.8 kg in controls. Furthermore, we found a trend toward a stronger reduction in blood pressure, fasting glucose, and HbA1c as well as an improved FINDRISK score in the intervention group, compared to controls. Although failing to reach statistical significance at the final assessment, this comprehensive lifestyle intervention showed a noticeable reduction in several cardiometabolic risk factors which may facilitate the prevention of diabetes.
KeywordsType 2 diabetes Cardiovascular risk Lifestyle coaching Health behavior Empowerment
The authors are indebted to the DAK Deutsche Angestellten-Krankenkasse Hannover, Germany, for recruitment of study participants, making available their training classrooms, and refunding the intervention program’s admission fee. The authors are also grateful to the reviewers for thoughtful comments on the manuscript and to Dr. Wolfgang Reimers for participation in the first statistical analyses. They also wish to thank Bengt Wennehorst for assistance in the final statistical analyses and Karel Vermeulen for helping with the implementation of the permutation based Augmented Mann-Whitney U test.
Compliance with Ethical Standards
This study was funded by a grant to Heike Englert from the German Diabetes Foundation (DDS) (grant number: 185/03/0).
Conflict of interest
Hans Diehl invented the Complete Health Improvement Program (CHIP; formerly Coronary Health Improvement Project); he was the director and is currently the consultant of the Lifestyle Medicine Institute, LLC (Loma Linda, CA, USA), which promotes the Complete Health Improvement Program. Klas Mildenstein developed the “ChipListe” food nutrition table utilized in the German CHIP program. Heike Englert was principle investigator of the German CHIP trial. Katharina Wennehorst, Brunhild Saliger, Corinna Tigges and Thomas Keil declared no conflict of interest.
Prior to initiating this research, the study protocol was reviewed by, and approval was obtained from, the ethical review committee Campus Charité Mitte (CCM) of the Charité-Universitätsmedizin Berlin, Germany. All procedures performed in this study were in accordance with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Participants granted written consent prior to participation in this study.
- ADA. (2006). Diagnosis and classification of diabetes mellitus. Diabetes Care, 29, 43–48.Google Scholar
- Bradley, C. (1994). The well-being questionnaire. In C. Bradley (Ed.), Handbook of psychology and diabetes: A guide to psychological measurement in diabetes research and practice (pp. 89–109). Switzerland, Harwood Academic: Chur.Google Scholar
- Buuren S. van, & Groothuis-Oudshoorn, K. (2011). mice: Multivariate imputation by chained equations in R. Journal of Statistical Software 45(3), ISSN 1548-7660.Google Scholar
- Costa, B., Barrio, F., Cabré, J. J., Piñol, J. L., Cos, X., Solé, C., … & Tuomilehto, J. (2012). Delaying progression to type 2 diabetes among high-risk Spanish individuals is feasible in real-life primary healthcare settings using intensive lifestyle intervention. Diabetologia, 55, 1319–28.Google Scholar
- Englert, H. S., Diehl, H. A., Greenlaw, R. L., & Aldana, S. (2012). The Effects of Lifestyle Modification on Glycemic Levels and Medication Intake: The Rockford CHIP. Primary Care at a Glance – Hot Topics and New Insights, www.intechopen.com
- Hanefeld, M., Koehler, C., Fuecker, K., Henkel, E., Schaper, F., & Temelkova-Kurktschiev, T. (2003). Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose—The risk factor in impaired glucose tolerance for atherosclerosis and diabetes study. Diabetes care, 26, 868–874.CrossRefPubMedGoogle Scholar
- Hermanns, N., Kulzer, B., Gorges, D., Schwarz, P., & Haak, T. (2009). Wie viel Gewichtsabnahme ist für die Erzielung eines positiven Effekts in Hinblick auf die Prävention des Typ 2 Diabetes notwendig? Diabetologie und Stoffwechsel, 4, 256.Google Scholar
- Klein, S., Sheard, N. F., Pi-Sunyer, X., Daly, A., Wylie-Rosett, J., Kulkarni, K., & Clark, N. G. (2004). Weight management through lifestyle modification for the prevention and management of type 2 diabetes: Rationale and strategies—A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. Diabetes Care, 27, 2067–2073.Google Scholar
- Kurth, B. M. (2012). Erste Ergebnisse aus der „Studie zur Gesundheit Erwachsener in Deutschland “(DEGS). Bundesgesundheitsblatt 2012, 55:980–990, Springer-Verlag 2012, doi: 10.1007/s00103-011-1504-5.
- Liebl, A., Neiss, A., Spannheimer, A., Reitberger, U., Wieseler, B., Stammer, H., & Goertz, A. (2002). Complications, comorbidity, and blood glucose control in type 2 diabetes mellitus patients in Germany—Results from the CODE-2™ study. Experimental and Clinical Endocrinology and Diabetes, 110, 10–16. doi: 10.1055/s-2002-19988.CrossRefPubMedGoogle Scholar
- Look AHEAD Research Group. (2007). Reduction in weight and cardiovascular disease risk factors in individuals with type 2 diabetes: one-year results of the look AHEAD trial. Diabetes Care, 30, 1374–1383.Google Scholar
- Ma, J., Yank, V., Xiao, L., Lavori, P. W., Wilson, S. R., Rosas, L. G., & Stafford, R. S. (2012). Translating the Diabetes Prevention Program lifestyle intervention for weight loss into primary care: A randomized trial. Archives of Internal Medicine, 173, 113–121.Google Scholar
- Mancia, G., De Backer, G., Dominiczak, A., Cifkova, R., Fagard, R., Germano, G., & O'Brien, E. (2007). 2007 Guidelines for the management of arterial hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal, 28, 1462–1536.PubMedGoogle Scholar
- Morton, D., Rankin, P., Kent, L., & Dysinger, W. (2014). The Complete Health Improvement Program (CHIP): History, Evaluation, and Outcomes. American Journal of Lifestyle Medicine. doi: 10.1177/1559827614531391.
- Schulz, K. F., Altman, D. G., & Moher, D. for the CONSORT Group (2010). CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials. Annals of Internal Medicine. 152.Google Scholar
- Shurney, D., Hyde, S., Hulsey, K., Elam, R., Cooper, A., & Groves, J. (2012). CHIP lifestyle program at Vanderbilt University demonstrates an early ROI for a diabetic cohort in a workplace setting: A case study. Journal of Managed Care Medicine, 15, 5–15.Google Scholar
- Tigges, C., Wennehorst, K., Saliger, B., & Englert, H. (2015). CHIP Deutschland: Das sozial-kognitive Prozessmodell gesundheitlichen Handelns (HAPA) und die Verbesserung des Bewegungsverhaltens durch ein Lebensstilcoaching-Programm zur Primär- und Sekundärprävention des Diabetes mellitus Typ 2. Verhaltenstherapie, 25, 23–30.CrossRefGoogle Scholar
- Tuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hamalainen, H., Ilanne-Parikka, P., et al. (2001). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. New England Journal of Medicine, 344, 1343–1350.CrossRefPubMedGoogle Scholar
- Wadden, T. A., West, D. S., Neiberg, R. H., Wing, R. R., Ryan, D. H., Johnson, K. C., … & Vitolins, M. Z. (2009). One‐year Weight Losses in the Look AHEAD Study: Factors Associated With Success. Obesity, 17(4), 713-722.Google Scholar
- Wadden, T. A., Volger, S., Sarwer, D. B., Vetter, M. L., Tsai, A. G., Berkowitz, R. I., … & Moore, R. H. (2011). A two-year randomized trial of obesity treatment in primary care practice. New England Journal of Medicine, 365(21), 1969-1979.Google Scholar
- Ware, J. E., Kosinski, M., & Keller, S. D. (1998). SF-12: How to score the SF-12 physical and mental health summary scales (3rd ed.). Lincoln: QualityMetric Incorporated.Google Scholar